His primary scientific interests are in Internal medicine, COPD, Surgery, Respiratory disease and Physical therapy. His Internal medicine study frequently draws connections between related disciplines such as Cardiology. His research in COPD intersects with topics in Vital capacity, Cohort study, Pulmonary function testing, Severity of illness and Pediatrics.
The concepts of his Respiratory disease study are interwoven with issues in Gastroenterology, Lung volumes, Cause of death, Asthma and Health education. His work deals with themes such as Corticosteroid and Etiology, which intersect with Asthma. His work carried out in the field of Physical therapy brings together such families of science as Obstructive lung disease and MEDLINE.
The scientist’s investigation covers issues in Internal medicine, COPD, Physical therapy, Pulmonary disease and Cardiology. His Internal medicine research focuses on Surgery and how it relates to Respiratory disease. He has included themes like Exacerbation, Prospective cohort study, Spirometry and Intensive care medicine in his COPD study.
His research in Spirometry intersects with topics in Vital capacity and FEV1/FVC ratio. His study in Physical therapy is interdisciplinary in nature, drawing from both Obstructive lung disease, Severity of illness and Epidemiology. His biological study spans a wide range of topics, including Young adult and Pediatrics.
Peter Lange spends much of his time researching COPD, Internal medicine, Fluticasone propionate, Exacerbation and Vilanterol. His COPD research incorporates themes from Pulmonary disease, Hazard ratio, Cohort study and Population study. His Population study research includes elements of FEV1/FVC ratio, Chronic bronchitis, Chronic cough, Prospective cohort study and Spirometry.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Cardiology. His Fluticasone propionate research incorporates elements of Fluticasone and Medication use. Peter Lange combines subjects such as Randomized controlled trial, Quality of life, Pulmonary rehabilitation, Proportional hazards model and Lung function with his study of Exacerbation.
His scientific interests lie mostly in Internal medicine, COPD, Exacerbation, Population study and Pulmonary disease. In his work, Inhalation is strongly intertwined with Gastroenterology, which is a subfield of Internal medicine. His COPD study integrates concerns from other disciplines, such as Vilanterol, Lung function, Fluticasone propionate, Cardiology and Fluticasone.
His Exacerbation research is multidisciplinary, relying on both Schizophrenia, Blood eosinophil, Randomized controlled trial and Quality of life, Pulmonary rehabilitation. The various areas that Peter Lange examines in his Population study study include Prospective cohort study and FEV1/FVC ratio. His studies in Pulmonary disease integrate themes in fields like Cardiorespiratory fitness, Risk of death and Long term risk.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A 15-year follow-up study of ventilatory function in adults with asthma.
Peter Lange;Jan Parner;Jørgen Vestbo;Peter Schnohr.
The New England Journal of Medicine (1998)
Prognostic value of nutritional status in chronic obstructive pulmonary disease
Charlotte Landbo;Eva Prescott;Peter Lange;Jørgen Vestbo.
American Journal of Respiratory and Critical Care Medicine (1999)
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study
Judith Garcia-Aymerich;Peter Lange;Marta Benet;Peter Schnohr.
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
Jøorgen Vestbo;Jøorgen Vestbo;Torben Søorensen;Peter Lange;Peter Lange;Anders Brix.
The Lancet (1999)
Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
J Vestbo;E Prescott;P Lange.
American Journal of Respiratory and Critical Care Medicine (1996)
Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study.
Jørgen Vestbo;Eva Prescott;Thomas Almdal;Morten Dahl.
American Journal of Respiratory and Critical Care Medicine (2006)
Developing COPD: a 25 year follow up study of the general population
A Løkke;P Lange;H Scharling;P Fabricius.
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Peter Lange;Bartolome Celli;Alvar Agustí;Gorm Boje Jensen.
The New England Journal of Medicine (2015)
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Morten Dahl;Jørgen Vestbo;Peter Lange;Stig E. Bojesen.
American Journal of Respiratory and Critical Care Medicine (2007)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson;Frank Barnhart;Noushin Brealey;Jean Brooks.
The New England Journal of Medicine (2018)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: